These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9139496)

  • 21. Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes.
    Netter HJ; Macnaughton TB; Woo WP; Tindle R; Gowans EJ
    J Virol; 2001 Mar; 75(5):2130-41. PubMed ID: 11160717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity in chimpanzees of experimental hepatitis B vaccines prepared from intact hepatitis B virus, purified polypeptides, or polypeptide micelles.
    Tabor E; Howard CR; Skelly J; Snoy P; Goudeau A; Zuckerman AJ; Gerety RJ
    J Med Virol; 1982; 10(1):65-74. PubMed ID: 7130967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication.
    Wu C; Zhang X; Tian Y; Song J; Yang D; Roggendorf M; Lu M; Chen X
    J Gen Virol; 2010 Feb; 91(Pt 2):483-92. PubMed ID: 19812261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
    Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses.
    Kron MW; Engler T; Schmidt E; Schirmbeck R; Kochanek S; Kreppel F
    J Gene Med; 2011 Dec; 13(12):648-57. PubMed ID: 22095925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune responses to hepatitis B virus surface and core antigens in mice, monkeys, and pigs after Accell particle-mediated DNA immunization.
    Fuller JT; Fuller DH; McCabe D; Haynes JR; Widera G
    Ann N Y Acad Sci; 1995 Nov; 772():282-4. PubMed ID: 8546409
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw2, adr, ayw3) in measuring the immune response after vaccination.
    Heijtink RA; Bergen Pv; Melber K; Janowicz ZA; Osterhaus AD
    Vaccine; 2002 May; 20(17-18):2191-6. PubMed ID: 12009272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
    Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
    Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees.
    Natuk RJ; Lubeck MD; Chanda PK; Chengalvala M; Wade MS; Murthy SC; Wilhelm J; Vernon SK; Dheer SK; Mizutani S
    AIDS Res Hum Retroviruses; 1993 May; 9(5):395-404. PubMed ID: 8318268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence and functional analysis of the human adenovirus type 7 E3-gp19K protein from 17 clinical isolates.
    Hermiston TW; Hellwig R; Hierholzer JC; Wold WS
    Virology; 1993 Dec; 197(2):593-600. PubMed ID: 8249282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
    Li L; Tian YJ; Shen H; Zhao XP; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of adenovirus type 5 early region 3 in the pathogenesis of ocular disease and cell culture infection.
    Trousdale MD; Nóbrega R; Stevenson D; Nakamura T; dos Santos PM; Labree L; McDonnell PJ
    Cornea; 1995 May; 14(3):280-9. PubMed ID: 7600812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species.
    Eloit M; Adam M
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1583-9. PubMed ID: 9049365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration.
    Lubeck MD; Natuk RJ; Chengalvala M; Chanda PK; Murthy KK; Murthy S; Mizutani S; Lee SG; Wade MS; Bhat BM
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1443-9. PubMed ID: 7888199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
    Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
    World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.
    Catalucci D; Sporeno E; Cirillo A; Ciliberto G; Nicosia A; Colloca S
    J Virol; 2005 May; 79(10):6400-9. PubMed ID: 15858023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C; Peng G; Jin X; Tang J; Chen Z
    Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helper independent recombinant adenovirus vectors: expression of HIV env or HBV surface antigen.
    Chanda PK; Natuk RJ; Dheer SK; Lubeck MD; Bhat BM; Mason BB; Greenberg L; Mizutani S; Davis AR; Hung PP
    Int Rev Immunol; 1990; 7(1):67-77. PubMed ID: 2132880
    [No Abstract]   [Full Text] [Related]  

  • 40. [Recombinant replication-defective adenovirus based rabies vaccine].
    Li WH; Zhang Y; Wang SH; Liu L; Yang F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):650-4. PubMed ID: 14714304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.